Marijuana ( DrugBank: Marijuana )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	3

13. Multiple sclerosis/Neuromyelitis optica

---

Clinical trials : 3,342 /  Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03172741 (ClinicalTrials.gov)	January 2017	25/5/2017	The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis	The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis	Multiple Sclerosis	Drug: Medical Marijuana;Drug: Placebo	Colorado State University	NULL	Withdrawn	21 Years	74 Years	All	0	Phase 2/Phase 3	NULL
2	NCT02898974 (ClinicalTrials.gov)	September 2016	6/9/2016	Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis	Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis: An Observational Case-control Study	Multiple Sclerosis	Behavioral: Medical Marijuana	Colorado State University	William R. Shaffer, M.D.	Completed	30 Years	60 Years	All	22		United States
3	NCT01037088 (ClinicalTrials.gov)	December 2009	17/12/2009	Effects of Vaporized Marijuana on Neuropathic Pain	CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain	Neuropathic Pain;Reflex Sympathetic Dystrophy;Peripheral Neuropathy;Post-herpetic Neuralgia;Spinal Cord Injury;Multiple Sclerosis	Drug: Mild dose cannabis;Drug: Low dose cannabis;Drug: Cannabis	University of California, Davis	Center for Medicinal Cannabis Research;VA Northern California Health Care System	Completed	18 Years	70 Years	All	44	Phase 1/Phase 2	United States